Abstract: Embodiments of the invention employ frequency selective surfaces that resonate at defined frequencies depending on geometry. Tag-based embodiments allow the ability to have passive, battery-free, systems that can be used for applications including but not limited to inventory tracking, locating, and indoor radar (e.g. determining whether something labeled with a tag is in range of a particular wireless network signal). The shape of the resonator, among other available factors, influences the interference frequency. Embodiments may include metal based tags on a non-conductive material that will be used to disturb, for example, frequencies from 3 KHz to 300 GHz. These disturbances at specific resonant frequencies are useable to, for example, locate the tags/labels using WiFi Mapping, sending a WiFi signal and getting unique feedback on a router.

Abstract: Described herein are integrated circuit devices formed using perovskite materials. Perovskite materials with a similar crystal structure and different electrical properties can be layered to realize a transistor or memory device. In some embodiments, a ferroelectric perovskite can be incorporated into a device with other perovskite films to form a ferroelectric memory device.

Abstract: A method for determining an environment in which a user is located is described. The method includes receiving a plurality of sets of audio data based on sounds emitted in a plurality of environments. Each of the plurality of environments has a different combination of objects. The method further includes receiving input data regarding the plurality of environments, and training an artificial intelligence (AI) model based on the plurality of sets of audio data and the input data. The method includes applying the AI model to audio data captured from an environment surrounding the first user to determine a type of the environment.

Abstract: A method includes receiving a first facial framework and a first captured image of a face. The first facial framework corresponds to the face at a first frame and includes a first facial mesh of facial information. The method also includes projecting the first captured image onto the first facial framework and determining a facial texture corresponding to the face based on the projected first captured image. The method also includes receiving a second facial framework at a second frame that includes a second facial mesh of facial information and updating the facial texture based on the received second facial framework. The method also includes displaying the updated facial texture as a three-dimensional avatar. The three-dimensional avatar corresponds to a virtual representation of the face.

Abstract: A method (300) includes receiving a first facial framework (144a) and a first captured image (130a) of a face (20). The first facial framework corresponds to the face at a first frame and includes a first facial mesh (142a) of facial information (140). The method also includes projecting the first captured image onto the first facial framework and determining a facial texture (212) corresponding to the face based on the projected first captured image. The method also includes receiving a second facial framework (144b) at a second frame that includes a second facial mesh (142b) of facial information and updating the facial texture based on the received second facial framework. The method also includes displaying the updated facial texture as a three-dimensional avatar (160). The three-dimensional avatar corresponds to a virtual representation of the face.

Abstract: Various compounds and pharmaceutically acceptable salts thereof are provided capable of binding cyclin-dependent kinase inhibitor 1B. The compounds can have a structure according to Formula I or Formula II as detailed herein. The compounds can include SJ747, SJ749, SJ755, SJ757. Pharmaceutical formulations containing the compounds or pharmaceutically acceptable salts are also provided along with methods of use thereof. The formulations and methods can be useful for treating cancer. In some aspects, the cancer is associated with a mislocalization of the intrinsically disordered protein p27. In some aspects, the cancer is resistant to an anticancer therapy. The pharmaceutical formulation can therefore include a second active agent and/or can be given in combination with a second active agent such as a cancer therapeutic. In various aspects, methods of promoting reentry into the cell division cycle in a subject in need thereof using compounds and formulations described herein are also provided.

Abstract: Disclosed herein are system, method, and computer program product embodiments for a dynamic email content engine. An embodiment operates by selecting a subscriber record from a database. The embodiment adds a first content item to a content pool based on a first rule in a set of rules, wherein the first rule is applied based on a characteristic of the content item or a persona record assigned to the subscriber record. The embodiments adds a second content item to the content pool based on a second rule in the set of rules. The embodiment ranks the first content item and the second content item in the content pool based on a first priority value and a second priority value. The embodiment assigns the first content item to the subscriber record based on the ranking.

Abstract: A method (300) includes receiving a first facial framework (144a) and a first captured image (130a) of a face (20) The first facial framework corresponds to the face at a first frame and includes a first facial mesh (142a) of facial information (140). The method also includes projecting the first captured image onto the first facial framework and determining a facial texture (212) corresponding to the face based on the projected first captured image. The method also includes receiving a second facial framework (144b) at a second frame that includes a second facial mesh (142b) of facial information and updating the facial texture based on the received second facial framework. The method also includes displaying the updated facial texture as a three-dimensional avatar (160). The three-dimensional avatar corresponds to a virtual representation of the face.

Abstract: Disclosed herein are system, method, and computer program product embodiments for assigning a content item to a subscriber record. Embodiments include electing a subscriber record from a database and assigning a persona record to the selected subscriber record. Then, a first and a second content item are added to a content pool based on a first and a second rule, respectively, where the first and the second rule are applied based on the persona record. Embodiments also include ranking the first content item and the second content item based on a first priority value and a second priority value associated with the first and the second rule, respectively. Then, the first content item is assigned to the subscriber record based on the ranking.

Abstract: Embodiments of the invention employ frequency selective surfaces that resonate at defined frequencies depending on geometry. Tag-based embodiments allow the ability to have passive, battery-free, systems that can be used for applications including but not limited to inventory tracking, locating, and indoor radar (e.g. determining whether something labeled with a tag is in range of a particular wireless network signal). The shape of the resonator, among other available factors, influences the interference frequency. Embodiments may include metal based tags on a non-conductive material that will be used to disturb, for example, frequencies from 3 KHz to 300 GHz. These disturbances at specific resonant frequencies are useable to, for example, locate the tags/labels using WiFi Mapping, sending a WiFi signal and getting unique feedback on a router.

Abstract: The compounds of the invention are antagonists of MDM2 and MDMX, with excellent specificity for MDM2 and MDMX over other proteins, and with selective binding affinity to MDMX over MDM2. The compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The compounds of the invention are antagonists of MDM2 and MDMX, with excellent specificity for MDM2 and MDMX over other proteins, and with selective binding affinity to MDMX over MDM2. The compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: Disclosed herein are system, method, and computer program product embodiments for a dynamic email content engine. An embodiment operates by selecting a subscriber record from a database. The embodiment adds a first content item to a content pool based on a first rule in a set of rules, wherein the first rule is applied based on a characteristic of the content item or a persona record assigned to the subscriber record. The embodiments adds a second content item to the content pool based on a second rule in the set of rules. The embodiment ranks the first content item and the second content item in the content pool based on a first priority value and a second priority value. The embodiment assigns the first content item to the subscriber record based on the ranking.

Abstract: The compounds of the invention are antagonists of MDM2 and MDMX, with excellent specificity for MDM2 and MDMX over other proteins, and with selective binding affinity to MDMX over MDM2. The compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The compounds of the invention are antagonists of MDM2 and MDMX, with excellent specificity for MDM2 and MDMX over other proteins, and with selective binding affinity to MDMX over MDM2. The compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The compounds of the invention are antagonists of MDM2 and MDMX, with excellent specificity for MDM2 and MDMX over other proteins, and with selective binding affinity to MDMX over MDM2. The compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The compounds of the invention are antagonists of MDM2 and MDMX, with excellent specificity for MDM2 and MDMX over other proteins, and with selective binding affinity to MDMX over MDM2. The compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The compounds of the invention are antagonists of MDM2 and MDMX, with excellent specificity for MDM2 and MDMX over other proteins, and with selective binding affinity to MDMX over MDM2. The compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.